Back to top

earnings-preview: Archive

Zacks Equity Research

What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q2 Earnings

Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

GEHCPositive Net Change

Zacks Equity Research

Stay Ahead of the Game With Teva Pharmaceutical Industries (TEVA) Q2 Earnings: Wall Street's Insights on Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Teva Pharmaceutical Industries (TEVA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

TEVAPositive Net Change

Zacks Equity Research

Ahead of Enterprise Products (EPD) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Enterprise Products (EPD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

EPDPositive Net Change

Zacks Equity Research

Insights Into Vulcan (VMC) Q2: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Vulcan (VMC) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

VMCNegative Net Change

Zacks Equity Research

Unlocking Q2 Potential of Alnylam (ALNY): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Alnylam (ALNY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

ALNYNegative Net Change

Zacks Equity Research

Exploring Analyst Estimates for Ingersoll (IR) Q2 Earnings, Beyond Revenue and EPS

Beyond analysts' top-and-bottom-line estimates for Ingersoll (IR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

IRNegative Net Change

Zacks Equity Research

Monolithic (MPWR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Besides Wall Street's top-and-bottom-line estimates for Monolithic (MPWR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

MPWRNegative Net Change

Zacks Equity Research

Seeking Clues to Teladoc (TDOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

TDOCNegative Net Change

Zacks Equity Research

Western Union (WU) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top-and-bottom-line estimates for Western Union (WU), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

WUNegative Net Change

Zacks Equity Research

Air Products and Chemicals (APD) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Air Products and Chemicals (APD) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

APDPositive Net Change